Championing our Healthcare Professionals: Smith & Nephew Launches Awareness
LONDON, September 9, 2013
LONDON, September 9, 2013 /PRNewswire/ --
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business,
is today launching an awareness campaign to highlight the important work done
by healthcare professionals.
(Photo: http://photos.prnewswire.com/prnh/20130909/638344-a )
(Photo: http://photos.prnewswire.com/prnh/20130909/638344-b )
(Photo: http://photos.prnewswire.com/prnh/20130909/638344-c )
(Photo: http://photos.prnewswire.com/prnh/20130909/638344-d )
Smith & Nephew has been supporting healthcare professionals for over 150
years. Today, the Company works with surgeons and nurses to provide
life-changing treatments, to develop innovative products and, through the
provision of medical education, to enhance skills and widen access to advanced
medical technology. Smith & Nephew representatives see, first-hand, the
extraordinary work these surgeons and nurses do, often in high-pressure,
challenging situations, and has developed this campaign to highlight the
crucial contribution these individuals make to society.
The campaign will launch with a series of advertisements in the UK & Ireland.
These will feature in the national press and run on billboards. The
advertisements are designed to increase public awareness of the important work
these professionals do, and the skills they need to perform at the highest
Commenting on the launch, Smith & Nephew's Chief Executive Officer Olivier
"Smith & Nephew is proud to support the vital role that surgeons and nurses
play in society. They are highly skilled professionals facing intense
pressures every day of their working lives. We make the products that help
them do their job and they are essential in helping us innovate.
"Surgeons and nurses deserve our support and our respect. You can have the
best products in the world but they are nothing without the right pair of
hands to use them."
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping
improve people's lives. With leadership positions in Orthopaedic
Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith &
Nephew has around 11,000 employees and a presence in more than 90 countries.
Annual sales in 2012 were more than $4.1 billion. Smith & Nephew is a member
of the FTSE100 (LSE: SN, NYSE: SNN).
For more information about Smith & Nephew, please visit:
This document may contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth and
trading margins, market trends and our product pipeline are forward-looking
statements. Phrases such as "aim", "plan", "intend", "anticipate",
"well-placed", "believe", "estimate", "expect", "target", "consider" and
similar expressions are generally intended to identify forward-looking
statements. Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual results to
differ materially from what is expressed or implied by the statements. For
Smith & Nephew, these factors include: economic and financial conditions in
the markets we serve, especially those affecting health care providers, payors
and customers; price levels for established and innovative medical devices;
developments in medical technology; regulatory approvals, reimbursement
decisions or other government actions; product defects or recalls; litigation
relating to patent or other claims; legal compliance risks and related
investigative, remedial or enforcement actions; strategic actions, including
acquisitions and dispositions, our success in integrating acquired businesses,
and disruption that may result from changes we make in our business plans or
organisation to adapt to market developments; and numerous other matters that
affect us or our markets, including those of a political, economic, business,
competitive or reputational nature. Please refer to the documents that Smith &
Nephew has filed with the U.S. Securities and Exchange Commission under the
U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's
most recent annual report on Form 20-F, for a discussion of certain of these
Any forward-looking statement is based on information available to Smith &
Nephew as of the date of the statement. All written or oral forward-looking
statements attributable to Smith & Nephew are qualified by this caution. Smith
& Nephew does not undertake any obligation to update or revise any
forward-looking statement to reflect any change in circumstances or in Smith &
^à Trademark of Smith & Nephew. Registered US Patent and Trademark Office.
Contact: Enquiries: Media, Charles Reynolds, +44(0)20-7401-7646, Smith &
Nephew; Andrew Mitchell / Justine McIlroy, +44(0)20-7404-5959, Brunswick;
Investors, Phil Cowdy, +44(0)20-7401-7646, Smith & Nephew
Press spacebar to pause and continue. Press esc to stop.